Recruiting

Natera CRC Screening Test

Sponsor:

Natera, Inc.

Code:

NCT07046585

Conditions

Colo-rectal Cancer

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.

Conditions

Colo-rectal Cancer

Study ID

NCT07046585

Start date

May 30, 2025

Status verified date

Dec, 2025

Completion date

Sep 30, 2033

Anticipated

Primary completion date

Jul 10, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Signed informed consent.
2. 40 years of age or older at the time of consent.
3. Planning or intending to undergo a standard of care colonoscopy.
4. Able to tolerate venipuncture for research draw(s).
5. Able and willing to provide blood samples within the 120 days prior to a standard-of-care pre-bowel preparation procedure and colonoscopy procedure.
6. Willing and able to comply with the study visit schedule and study requirements.

Exclusion Criteria:

1. Any prior history of any kind of malignancy (exception: participants who have undergone surgical removal of skin squamous cell or basal cell cancers may be enrolled, provided the procedure was completed at least 12 months prior to consent for the study).
2. Had a complete colonoscopy with adequate bowel preparation in the previous nine (9) years.
3. Undergoing diagnostic colonoscopy for the investigation of symptoms.
4. Up to date with colorectal cancer screening from any non-invasive test.
5. Precancerous findings on most recent colonoscopy.
6. Had a prior colorectal resection for any reason other than sigmoid diverticular disease.
7. Known personal history of any of the following high-risk conditions:

7a. Inflammatory bowel disease. 7b. Known hereditary condition that would increase risk of colorectal cancer (example Lynch Syndrome).

Study Design

Enrollment

25000 participants

Anticipated

Interventions and Outcome Measures

Arms

Participants at average risk for colorectal cancer

Participants 40 years of age or older at time of consent, planning or intending to undergo asymptomatic screening colonoscopy.

Primary outcome measure

  • Primary Outcome [ Time Frame: 24 months ]

Central Contacts and Locations

Central contacts

Locations

Natera, Inc

Recruiting

Austin, Texas, United States, 78753

More Information

Sponsor

Natera, Inc.

Last update posted

Dec 12, 2025

Last verified

Dec, 2025

Keywords

  • colorectal cancer
  • colon cancer
  • early cancer detection

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Natera, Inc. on 2025-12-12.